| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 363.00M | 368.00M | 386.00M | 413.00M | 412.00M | 210.00M |
| Gross Profit | 290.00M | 338.00M | 354.00M | 399.00M | 412.00M | 220.00M |
| EBITDA | 443.00M | 333.00M | 347.00M | -27.00M | -12.00M | 22.00M |
| Net Income | 422.00M | 333.00M | 347.00M | 394.00M | 404.00M | 206.00M |
Balance Sheet | ||||||
| Total Assets | 4.15B | 3.88B | 3.93B | 3.71B | 3.02B | 2.42B |
| Cash, Cash Equivalents and Short-Term Investments | 6.00M | 4.00M | 5.00M | 5.00M | 17.00M | 462.00M |
| Total Debt | 350.00M | 260.00M | 510.00M | 501.00M | 231.00M | 0.00 |
| Total Liabilities | 387.00M | 316.00M | 590.00M | 606.00M | 316.00M | 25.00M |
| Stockholders Equity | 3.76B | 3.56B | 3.34B | 3.10B | 2.70B | 2.39B |
Cash Flow | ||||||
| Free Cash Flow | 386.00M | 376.00M | 118.00M | -259.00M | -578.00M | 136.00M |
| Operating Cash Flow | 386.00M | 376.00M | 118.00M | -259.00M | -578.00M | 136.00M |
| Investing Cash Flow | 1.00M | 0.00 | 120.00M | -303.00M | -601.00M | 105.00M |
| Financing Cash Flow | -390.00M | -379.00M | -118.00M | 257.00M | 135.00M | -87.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ― | 3.23 | 11.52% | 3.53% | 13.92% | 29.82% | |
76 Outperform | £1.70B | ― | 2.22% | 2.40% | 64.34% | 77.61% | |
73 Outperform | £408.79M | 7.48 | 44.99% | 5.73% | ― | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | £264.67M | -1.21 | -6.58% | 8.18% | -9.72% | -25.25% | |
47 Neutral | ― | -5.44 | -25.87% | 1.43% | ― | ― | |
44 Neutral | ― | -1.48 | -47.36% | 3.45% | ― | ― |